PharmacoEconomics, 1170-7690

Journal

Publications

  1. Article › Research › Not peer-reviewed
  2. Published

    A fair innings for NICE?

    Nick Freemantle & Joanne Eastaugh, 1 Jan 2002, In: PharmacoEconomics. 20, 6, p. 389-391 3 p.

    Research output: Contribution to journalArticle

  3. Published

    A role of two-stage pharmacoeconomic appraisal?

    Nick Freemantle, 1 Jan 2003, In: PharmacoEconomics. 21, p. 761-767 7 p.

    Research output: Contribution to journalArticle

  4. Published

    Cost Effective Strategies in the Prevention of Diabetic Nephropathy

    Jonathan Rippin, Tony Barnett & Stephen Bain, 1 Jan 2004, In: PharmacoEconomics. 22, p. 9-28 20 p.

    Research output: Contribution to journalArticle

  5. Published
  6. Published
  7. Published

    Developing revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors: opportunity or threat?

    Rodney Taylor, 1 Jan 2002, In: PharmacoEconomics. 20, 15, p. 1031-1038 8 p.

    Research output: Contribution to journalArticle

  8. Published

    How much is the cost of blindness? Caveat Emptor

    Catherine Meads & Christopher Hyde, 1 Jan 2006, In: PharmacoEconomics. 24, 2, p. 207-209 3 p.

    Research output: Contribution to journalArticle

  9. Published
  10. Published

    New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

    Gregory Lip, 1 Jan 2009, In: PharmacoEconomics. 27, 10, p. 793-5 3 p.

    Research output: Contribution to journalArticle

  11. Published

    Real world trials to answer real world questions

    Nick Freemantle, Richard Hobbs, 1 Jan 2005, In: PharmacoEconomics. 23, p. 747-754 8 p.

    Research output: Contribution to journalArticle

  12. Published

    The applicability and generalizability of findings from clinical trials for health-policy decisions.

    Nick Freemantle, 1 Jan 2009, In: PharmacoEconomics. 27, 1, p. 5-10 6 p.

    Research output: Contribution to journalArticle

  13. Published

    Using health outcomes data to inform decision-making - Government Agency Perspective

    Rodney Taylor, 1 Jan 2001, In: PharmacoEconomics. 19, p. 33-38 6 p.

    Research output: Contribution to journalArticle

  14. Article › Research › Peer-reviewed
  15. Published
  16. Published
  17. Published
  18. Published
  19. E-pub ahead of print
  20. E-pub ahead of print

    Economic evaluation of childhood obesity interventions: reflections and suggestions

    Emma Frew, 11 Mar 2016, (E-pub ahead of print) In: PharmacoEconomics. 34, 8, p. 733-740

    Research output: Contribution to journalArticlepeer-review

  21. Published

    Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index

    Tracy Roberts, Karla Hemming & Melanie Calvert, Nov 2015, In: PharmacoEconomics. 33, 11, p. 1195-1214 20 p.

    Research output: Contribution to journalArticlepeer-review

  22. Published

    Exploring the use of cost-benefit analysis to compare pharmaceutical treatments for menorrhagia

    Sabina Sanghera, Emma Frew, Janesh Gupta & Tracy Roberts, Sep 2015, In: PharmacoEconomics. 33, 9, p. 957-965 9 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 Next